Medical device company ArKal Medical raises $17.5M
ArKal Medical, a Fremont, Calif. company that makes a continuous glucose monitoring system, has raised $17.5 million in a second round of funding. Thomas McNerney & Partners led the round with previous investors MedVentures Associates and Delphi Ventures participating.
Life sciences briefing: Thursday, Nov. 1, 2007
Featured companies: Asteres, HemaQuest Pharmaceuticals, Nanosphere, Novalar Pharmaceuticals, Tranzyme Pharma
(UPDATED: Expanded items for Nanosphere, HemaQuest and Transzyme. Moved Novalar to a separate item here.)
Diagnostic maker Nanosphere prices IPO at low end of range, raises up to $113M — Nanosphere, a Northbrook, Ill., biotech focused on nanotech-derived diagnostics, priced its IPO at $14 a share, at the low end of its estimated range. The company, which could sell as many as eight million shares, stands to raise up… Continue Reading
Life sciences briefing: Thursday, Aug. 16, 2007
Featured companies: Reliant Technologies, Leptos Biomedical, Calidora Skin Clinic
Reliant Tech seeks $95M IPO for dermatology lasers — Mountain View, Calif.-based Reliant Technologies, a developer of medical lasers for “skin rejuvenation” treatment, filed to raise as much as $95 million in an initial offering. The company currently markets two laser systems for skin treatment under the Fraxel brand name, and intends to launch a third one next year.
Oddly enough, Reliant Tech’s IPO filing comes just days after… Continue Reading